Abivax (ABVX) announces the pricing of its previously announced underwritten public offering of 10,156,000 American Depositary Shares, each representing one ordinary share of the company, in the United States at an offering price of $64.00 per ADS. Leerink Partners, Piper Sandler & Co. and Guggenheim Securities are acting as joint bookrunning managers for the offering. LifeSci Capital is acting as lead manager, with BTIG and Van Lanschot Kempen acting as co-managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX: